Corylifol A ameliorates muscle atrophy by inhibiting TAOK1/p38‐MAPK/FoxO3 pathway in cancer cachexia

• Main Authors: Ruiqin Zhang (Author), Qiang Shen (Author), Yueping Wang (Author), Xue Deng (Author), Jialing Fan (Author), Xiaofan Gu (Author), Meng Fan (Author), Kun Wei (Author), Chun‐Ru Cheng (Author), Wei‐Dong Zhang (Author), Xiong‐wen Zhang (Author), Xuan Liu (Author)
• Format: Book
• Published: Wiley, 2023-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Corylifol A (CYA) is one of the main active components of Psoralea corylifolia L. CYA had been reported to have ameliorating effects on dexamethasone‐induced atrophy of C2C12 mouse skeletal myotubes, but its effects on cancer cachexia were unclear. Here, we checked the influence...